SLC31A1 and neoplasm: Future studies should expand these observations in larger cohorts and incorporate ΔCopper alongside tumor profiling of CTR1, copper-dependent enzymes, and copper-regulated signaling pathways to refine patient selection and clarify mechanisms linking copper metabolism to neoadjuvant chemotherapy resistance.